Post-COVID Decentralized Trials Adoption in EU
Post-COVID Decentralized Trials Adoption in EU Decentralized Clinical Trials in the EU After COVID-19 The COVID-19 pandemic accelerated the adoption of decentralized clinical trials (DCTs) worldwide, including across the European Union (EU). Traditionally reliant on site-based models, EU regulators and sponsors had to adapt quickly to ensure trial continuity during lockdowns and travel restrictions. Remote…
Read More “Post-COVID Decentralized Trials Adoption in EU” »